|1.||Cong, Bin: 9 articles (01/2014 - 02/2002)|
|2.||Ling, Yi-Ling: 8 articles (05/2006 - 02/2002)|
|3.||Wang, Jing: 7 articles (01/2016 - 04/2008)|
|4.||Ma, Chunling: 7 articles (01/2014 - 02/2002)|
|5.||Rakonczay, Zoltán: 7 articles (08/2009 - 01/2002)|
|6.||Takács, Tamás: 7 articles (08/2009 - 06/2002)|
|7.||Boros, Imre: 7 articles (10/2007 - 01/2002)|
|8.||Kaszaki, József: 6 articles (10/2007 - 07/2002)|
|9.||Lonovics, János: 6 articles (10/2007 - 01/2002)|
|10.||Wen, Di: 5 articles (01/2014 - 10/2011)|
03/01/2008 - "The aim of this study was to investigate the effect of BV on cholecystokinin octapeptide (CCK-8)-induced acute pancreatitis (AP) in rats. "
01/01/2007 - "The aim of this study was to investigate the effects of EA on acute pancreatitis induced by cholecystokinin octapeptide (CCK) in rats. "
11/01/2001 - "The aim of this study was to investigate the potential effects of HSP preinduction by cold- (CWI) or hot-water immersion (HWI) on pro-inflammatory cytokine production (IL-1, IL-6, TNF-alpha) in cholecystokinin-octapeptide(CCK)-induced acute pancreatitis. "
01/01/1994 - "The aim of this work was to study in rats the temporal course of laboratory parameters and morphologic features in acute pancreatitis induced by cholecystokinin octapeptide (CCK-8) or by a closed duodenal loop. "
04/01/2007 - "CCK-8 at 2 nmol x kg(-1) x h(-1) caused severe edematous pancreatitis as evidenced by morphological and biochemical criteria. "
|2.||Body Weight (Weight, Body)
01/01/1984 - "The therapeutic potential of CCK-8 cannot be estimated until further studies are performed that demonstrate the efficacy of CCK-8 for decreasing body weight and that the safety of CCK-8 when it is administered repetitively for prolonged periods is established."
05/01/2011 - "There were no differential changes in body weight, body composition, resting energy expenditure, gastric emptying rate, CCK-8 levels, and appetite between young and older men during the study. "
07/01/1992 - "In daily injection studies, the anorectic activity of CCK-8 diminished rapidly, whereas the suppressant effects of A71623 on food intakes and body weight gains persisted throughout the 11-day treatment period. "
04/01/1990 - "Total food intake over the 77-day study was 5.4% greater for the CCK-8 group (P = .08): body weight gain was 8.3% greater (P = .006). "
06/01/1989 - "In an acute study, cholecystokinin octapeptide sulfate (CCK) in doses of 1, 10 or 100 micrograms/kg body weight was injected intraperitoneally into rats just prior to the dark cycle. "
05/01/1994 - "The current in vitro study showed that the contractile responses of isolated smooth muscle cells of the gallbladder to CCK-8 are not impaired in patients with gallstones."
04/28/2014 - "The disturbance in SO motility may play a role in pigment gallstone formation, and changes in serum VIP and CCK-8 may be important causes of SO dysfunction."
01/01/2005 - "Cholecystokinin-octapeptide prophylaxis was not effective in preventing TPN-associated gallstones. "
01/01/2005 - "Cholecystokinin-octapeptide was not effective in preventing the formation of gallstones (3 stones in infants receiving CCK, P = .51). "
01/01/2005 - "The authors hypothesized that the use of cholecystokinin-octapeptide (CCK), given at the time of TPN administration, would prevent gallstone formation in a high-risk group of patients with TPN. "
01/01/2012 - "In the presented study, infusion of CCK-8 at physiological concentration combining with conditional training significantly increased the CRD-induced CPA scores, and enhanced the pain affective memory retention. "
07/01/1993 - "Previous studies have shown that CCK-8 has distinct antiopioid effect in the central sites related with pain control and blood pressure control. "
06/01/2014 - "In 32 of these, sincalide triggered pain compared to 75 of the 155 patients with low GB-EF. "
08/01/2013 - "In this prospective study, 30 patients with functional biliary pain underwent biliary scintigraphy, CT cholangiography, and MR cholangiography before and during 45-minute sincalide infusions. "
01/01/2011 - "We have previously shown that CCK-8 could antagonize the analgesic effects of EA on pain-excited neurons (PENs) and pain-inhibited neurons (PINs) in the nucleus parafascicularis (nPf). "
07/01/2015 - "To study the potential function of miR-10b involved in the regulation of lung tumors, we monitored NSCLC cell behaviour including proliferation, apoptosis and cell cycle using CCK-8 and flow cytometry analysis. "
01/01/2015 - "In this study, immunohistochemistry, lentivirus mediated transfection, Transwell assay; CCK-8 assay, real-time PCR and flow cytometry were employed to confirm the roles of Foxp3 in the occurrence and development of cervical cancer. "
09/01/2015 - "Compounds 1-4 was in vitro evaluated for their cytotoxic activities by CCK-8 assay against five human cancer cell lines (SHSY-5Y, SMMC-7721, HepG2, Hela, and MCF-7) and their inhibitory effects on NO production in lipopolysaccharide-activated murine macrophage RAW264.7 cells. "
08/01/2015 - "The Τranswell chemotaxis and the CCK-8 assays were used to assess the migration and proliferation of the tumor cells, respectively. "
11/01/2014 - "CCK-8 method was used for evaluating cell proliferation, Transwell for cell invasion capacity in vitro, and tumor formation in nude mice for in vivo tumorigenicity. "
|2.||Taurocholic Acid (Sodium Taurocholate)
|3.||Dihydrotachysterol (AT 10)
|4.||Phospholipases A2 (Phospholipase A2)
|5.||Cyclooxygenase 2 (Cyclooxygenase-2)
|10.||Protein Kinases (Protein Kinase)
|2.||Drug Therapy (Chemotherapy)